Strong overexpression of CXCR3 axis components in childhood inflammatory bowel disease

Sebastian Schroepf1, Roland Kappler, Stephan Brand

  • 1Department of Pediatric Surgery, Research Laboratories, University of Munich, Munich, Germany.

Inflammatory Bowel Diseases
|September 18, 2010
PubMed

Insights

The CXCR3 axis is overexpressed in active Inflammatory Bowel Disease (IBD), indicating its role in disease development. A specific CXCL11 gene variant (rs6817952 A) is linked to increased risk in pediatric Crohn's disease and all ages with ulcerative colitis.

Area of Science:

  • Gastroenterology
  • Immunology
  • Genetics

Background:

  • Inflammatory Bowel Disease (IBD) is a complex polygenetic disorder.
  • Previous research linked a CXCL9 gene variant to pediatric Crohn's disease.
  • CXCL9, CXCL10, and CXCL11 are ligands for the CXCR3 receptor.

Purpose of the Study:

  • Investigate the colonic transcriptional activity of the CXCR3 axis in IBD.
  • Perform Single Nucleotide Polymorphism (SNP) genotyping of a CXCL11 polymorphism in IBD patients.
  • Analyze the association of the CXCL11 rs6817952 variant with IBD risk across pediatric and adult populations.

Main Methods:

  • Real-time PCR was used to analyze mRNA expression of CXCR3, CXCL9, CXCL10, CXCL11, and IL8 in colonic biopsies.
  • TaqMan SNP genotyping assay determined the CXCL11 rs6817952 nucleotide substitution.
  • The study included 501 German individuals with IBD (pediatric and adult) and 231 controls.

Main Results:

  • CXCR3 axis genes were significantly overexpressed in inflamed colonic tissue of pediatric Crohn's disease (CD) and ulcerative colitis (UC) patients.
  • The rs6817952 genotype variants were more prevalent in pediatric CD patients compared to controls.
  • Carriers of rs6817952 variants had an increased risk for UC across all age groups.

Conclusions:

  • The CXCR3 axis is significantly overexpressed in active IBD, suggesting a role in disease pathogenesis.
  • The rs6817952 A variant acts as a risk allele for pediatric CD and for UC in all age groups.
  • Further therapeutic studies are warranted to explore CXCR3 blockade for modulating intestinal inflammation in IBD.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...